Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses

Outcome
Finished, no results posted
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
1 January 2017
Ended
1 January 2020
Enrollment
150 participants
Sites
1
Primary outcomes
Diagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methods
Sponsor type
Academic / other
Results posted
No
Last update
25 August 2022

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy

Detailed description public domain (ClinicalTrials.gov)

A prospective study that compares the results using FNA contrast echoendoscopy versus standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors